期刊文献+

Diagnosis and management of late hepatic allograft dysfunction

Diagnosis and management of late hepatic allograft dysfunction
在线阅读 下载PDF
导出
摘要 Late hepatic allograft dysfunction (LHAD) is common after liver transplantation (LT) and can cause graft failure,retransplantation,or even death.A variety of etiologies including rejection,vascular complications,bile duct complications,recurrent diseases,infections,de novo diseases,neoplasms and drug toxicity can result in LHAD.The recurrent diseases have the potential to become the most serious problems facing LT in the future.It is difficult to differentiate late acute rejection from recurrent viral or autoimmune hepatitis.Accurate diagnosis of the cause of LHAD has therapeutic importance. Late hepatic allograft dysfunction (LHAD) is common after liver transplantation (LT) and can cause graft failure,retransplantation,or even death.A variety of etiologies including rejection,vascular complications,bile duct complications,recurrent diseases,infections,de novo diseases,neoplasms and drug toxicity can result in LHAD.The recurrent diseases have the potential to become the most serious problems facing LT in the future.It is difficult to differentiate late acute rejection from recurrent viral or autoimmune hepatitis.Accurate diagnosis of the cause of LHAD has therapeutic importance.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2005年第1期52-57,共6页 中国人民解放军军医大学学报(英文版)
关键词 liver transplantation late hepatic allograft dysfunction recurrent disease 肝脏移植 肝功能 并发症 血管疾病 自体免疫
  • 相关文献

参考文献22

  • 1[1]Jain A, Reyes J,Kashyap R et al.Long-term survival after liver transplantation in 4000 consecutive patients at a single center [J]. Ann Surg,2000; 232(4): 490.
  • 2[2]McCaughan GW, Zekry A.Pathogenesis of hepatitis C virus recurrence in the liver allograft [J].Liver Transpl,2002; 8(10 Suppl 1): S7.
  • 3[3]Selzner N, Durand F,Bernuau J et al.Conversion from cyclosporine to FK 506 in adult liver transplant recipients: a combined North American and European experience [J]. Transplantation,2001; 72(6): 1061.
  • 4[4]Jain A, Demetris AJ,Kashyap R et al.Does tacrolims offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1048 liver transplantations with a mean follow-up of 6 years [J]. Liver Transpl,2001; 7(7): 623.
  • 5[5]Jain D, Robert ME,Navarro V et al.Total fibrous obliteration of main portal vein and portal form venopathy in chronic hepatic allograft rejection [J]. Arch Pathol Lab Med,2004; 128 (1):64.
  • 6[6]McAlister VC,Peltekian KM,Malatjalian DA et al.Orthotopic transplantation using low-dose tacrolimus and sirolimus [J]. Liver Transpl,2001; 7(8): 701.
  • 7[7]Pastacaldi S,Teixeira R,Montalto P et al.Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes [J]. Liver Transpl,2001; 7(2): 75.
  • 8[8]Graziadei IW,Millonig G,Vogel W.Repeated graft loss caused by recurrent hepatic artery thombosis [J].Liver Transpl,2003; 9(9): 998.
  • 9[9]Pungpapong S, Manzarbeitia C,Ortiz J et al.Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation [J]. Liver Transpl,2002; 8(7): 582.
  • 10[10]Egawa H,Inomata Y,Uemoto S et al.Biliary anastomotic complications in 400 living related liver transplantaton [J]. World J Surg,2001; 25(10):1300.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部